Bio & Pharma
Hancom Carelink invests in bio big data venture 3bigs
Both companies will release this year a health management platform based on microbiomes
By Jan 26, 2023 (Gmt+09:00)
1
Min read
Most Read
Samsung steps up AR race with advanced microdisplay for smart glasses


When in S. Korea, it’s a ritual: Foreigners make stops at CU, GS25, 7-Eleven


Maybe Happy Ending: A robot love story that rewrote Broadway playbook


NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen


US auto parts tariffs take effect; Korea avoids heavy hit



South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big data analysis company 3Bigs.
The investment amount and stake were not disclosed, but industry experts say the transaction was worth billions of won.
3Bigs possesses know-how in analysis of bio big data. The company runs 3X-K Bank, a platform linking over 70 public bio databases; 3X-T Miner, a data provider that analyzes more than 30 million theses covered by the Science Citation Index Expanded; and 3X-M Omics, a multi-omics data analysis platform that converges information such as that on genome and protein clusters through next-generation sequencing.
In the first quarter this year, Hancom Carelink and 3bigs will roll out a health management platform based on microbiome, which is dubbed the “second genome.”
Write to Han-Gyeol Seon at always@hankyung.com
More to Read
-
Artificial intelligenceHancom Frontis to develop AI digital human, 3D scanning project
Jan 11, 2023 (Gmt+09:00)
1 Min read -
Cloud computingHancom to focus on cloud computing and AI services
Sep 07, 2022 (Gmt+09:00)
1 Min read -
Aerospace & DefenseHancom to launch South Korea’s first private satellite
May 18, 2022 (Gmt+09:00)
2 Min read
Comment 0
LOG IN